Abstract
Background: Pulmonary embolism (PE) is a common and fatal complication of COVID-19 infection. COVID-19's main clinical manifestations are not only pneumonia but also coagulation disorders. This study evaluates the prevalence of pulmonary embolism at CT pulmonary angiography (CTA) for positive coronavirus patients as well as the factors associated with PE severity. Materials and methods: This is a retrospective cross-sectional study that was conducted at King Faisal Medical Complex (KFMC) in Taif city of Saudi Arabia from June 2020 to June 2021. Data was collected from the picture archiving and communication system (PACs) for a total of 445 positive patients who underwent CT pulmonary angiography and analyzed using SPSS. Results: The mean age and gender of the male were 57.3 +/- 15.8 years and 64.5%, respectively. The prevalence of pulmonary embolism at CTA among patients with COVID-19 was found to be 8.1%. Bilateral segmental and bilateral subsegmental pulmonary embolism were found to be the most common sites for PE (16.7% for each). Furthermore, shortness of breath (SOB) was found to be the most common reported symptom among the respondents. Lastly, shortness of breath, chest pain, loss of taste or smell, D-dimer, and cardiac troponin were found to be significantly associated with PE (P-value = < 0.001, < 0.001, 0.001, < 0.001 and 0.037 respectively). Conclusion: Present results show that the prevalence of pulmonary embolism among COVID-19 patients with CT Pulmonary Angiography at KFMC is relatively low (8.1%) and most of the patients were from the ICU department. Early detection and treatment of COVID-19 patients with PE and APE complications are critical for lowering the mortality rate.